Abiopharma

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution AdvancingAmpligen® Toward Planned Phase 3 Development in Pancreatic Cancer

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Via Transportation (VIA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Kuehn Law Encourages Investors of Grocery Outlet Holding Corp. to Contact Law Firm

Vertical Aerospace Announces Financing Commitments of Approximately $100 Million to Advance Certification and Commercialisation

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

ESS Reschedules Second Quarter 2026 Financial Results Conference Call to Tuesday, August 11, 2026 at 5:00 p.m. Eastern Time

Founder Group Limited Secures First Aquaculture Contract, a US$1.2 million 1.4 MW rooftop system for a Terengganu shrimp farm

Rush Street Interactive to Participate at the Oppenheimer 29th Annual Technology, Internet & Communications Conference

Alliance Entertainment Reports Strong Engagement at Record Store Day Summer Camp